Home/Women’s Health Initiative Translational Unit (WHITU)
Women’s Health Initiative Translational Unit (WHITU)
The Women’s Health Initiative Translational Unit (WHITU) is comprised of clinicians, midwives, scientists, and allied health professionals who share a common goal to improve women’s health through medical research.
WHITU’s primary objective is to create an internationally recognised women’s health centre that holistically maximises women’s health and well-being. The goals of WHITU are to maximise equity, equality, health, and empowerment for all women by creating practices guided by evidence, as well as the lived experiences of women in a culturally respectful way.
WHITU engages with the community, community elders, and representatives and community health providSydnees to improve health literacy for all women at all stages of life.
This unit is unique with SWSLHD for a number of reasons:
The focus of WHITU is not on a single disease or group of diseases.
WHITU’s work will impact a significant portion of the community, as over 50% of the adult population is comprised of women.
WHITU will improve outcomes for women by having far reaching, significant medical and social benefits, but these benefits will also extend into the next generation resulting in benefits for children too.
WHITU combines academic research with commitment to improve service delivery within SWSLHD.
The WHITU academic unit won the 2019 Ingham Institute for Applied Medical Research publication award.
A PHARMACOKINETIC ASSESSMENT OF OPTIMAL DOSING, PREPARATION AND CHRONOTHERAPY OF ASPIRIN IN PREGNANCY. Renuka Shanmugalingam, XiaoSuo Wang, Gerald Munch, Ian Fulcher, Gaksoo Lee, Katrina Chau, Bei Xu, Roshika Kumar, Annemarie Hennessy, Angela Makris American Journal of Obstetric and Gynaecology (AJOG) DOI: https://doi.org/10.1016/j.ajog.2019.04.027
FACTORS THAT INFLUENCE ADHERENCE TO ASPIRIN THERAPY IN THE PREVENTION OF PREECLAMPSIA AMONGST HIGH-RISK PREGNANT WOMEN: A MIXED METHOD ANALYSIS Renuka Shanmugalingam, Zelalem Mengesha, Stephanie Notaras, Pranee Liamputtong, Ian Fulcher, Gaksoo Lee, Roshika Kumar, Annemarie Hennessy, Angela Makris Plos One 2020 DOI : https://doi.org/10.1371/journal.pone.0229622
THE CLINICAL INFLUENCE OF NON-ADHERENCE WITH PROPHYLACTIC ASPIRIN IN PREVENTING PREECLAMPSIA IN HIGH-RISK PREGNANCIES: A MULTI-CENTRE PROSPECTIVE, OBSERVATIONAL, COHORT STUDY. Renuka Shanmugalingam, XiaoSuo Wang, Penelope Motum, Ian Fulcher, Gaksoo Lee, Roshika Kumar, Annemarie Hennessy, Angela Makris. Hypertension. 2020;75:1125–1132 DOI : doi.org/10.1161/HYPERTENSIONAHA.119.14107
THE 15-EPILIPOXIN-A4 PATHWAY WITH PROPHYLACTIC ASPIRIN IN PREVENTING PREECLAMPSIA: A LONGITUDINAL COHORT STUDY Renuka Shanmugalingam, XiaoSuo Wang, Penelope Motum, Ian Fulcher, Gaksoo Lee, Roshika Kumar, Annemarie Hennessy, Angela Makris. Journal of Clinical Endocrine and Metabolism (JCEM) 2020. DOI : https://doi.org/10.1210/clinem/dgaa642
THE 2021 INTERNATIONAL SOCIETY FOR THE STUDY OF HYPERTENSION IN PREGNANCY CLASSIFICATION, DIAGNOSIS & MANAGEMENT RECOMMENDATION FOR INTERNATIONAL PRACTICE. Laura Magee, Mark Brown, David Hall, Sanjay Gupte, Annemarie Hennessy, Ananth Karumanchi, Louise Kenny, Fergus McCarthy, Jenny Myers, Liona Poon, Sarosh Rana, Shigeru Saito, Anee Catherine Staff, Eleni Tsigas, Peter von Dadelszen. Pregnacy Hypertension 2022. DOI: https://doi.org/10.1016/j.preghy.2021.09.008